These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 30684656)

  • 1. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.
    Lauschke VM; Ingelman-Sundberg M
    Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variant discovery using next-generation sequencing and its future role in pharmacogenetics.
    Russell LE; Schwarz UI
    Pharmacogenomics; 2020 May; 21(7):471-486. PubMed ID: 32338137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A paradigm shift in pharmacogenomics: From candidate polymorphisms to comprehensive sequencing.
    Zhou Y; Koutsilieri S; Eliasson E; Lauschke VM
    Basic Clin Pharmacol Toxicol; 2022 Dec; 131(6):452-464. PubMed ID: 35971800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted next generation sequencing as a tool for precision medicine.
    Gulilat M; Lamb T; Teft WA; Wang J; Dron JS; Robinson JF; Tirona RG; Hegele RA; Kim RB; Schwarz UI
    BMC Med Genomics; 2019 Jun; 12(1):81. PubMed ID: 31159795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Next-Generation Sequencing for Comprehensive Genetic Profiling of Pharmacogenes.
    Han SM; Park J; Lee JH; Lee SS; Kim H; Han H; Kim Y; Yi S; Cho JY; Jang IJ; Lee MG
    Clin Pharmacol Ther; 2017 Mar; 101(3):396-405. PubMed ID: 27727443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How and why to screen for CYP2D6 interindividual variability in patients under pharmacological treatments.
    De Gregori M; Allegri M; De Gregori S; Garbin G; Tinelli C; Regazzi M; Govoni S; Ranzani GN
    Curr Drug Metab; 2010 Mar; 11(3):276-82. PubMed ID: 21171195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirements for comprehensive pharmacogenetic genotyping platforms.
    Lauschke VM; Ingelman-Sundberg M
    Pharmacogenomics; 2016 Jun; 17(8):917-24. PubMed ID: 27248710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of whole-genome sequencing-based pharmacogenetic profiling.
    Caspar SM; Schneider T; Stoll P; Meienberg J; Matyas G
    Pharmacogenomics; 2021 Feb; 22(3):177-190. PubMed ID: 33517770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges Related to the Use of Next-Generation Sequencing for the Optimization of Drug Therapy.
    Zhou Y; Lauschke VM
    Handb Exp Pharmacol; 2023; 280():237-260. PubMed ID: 35792943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics in the era of next generation sequencing - from byte to bedside.
    Russell LE; Zhou Y; Almousa AA; Sodhi JK; Nwabufo CK; Lauschke VM
    Drug Metab Rev; 2021 May; 53(2):253-278. PubMed ID: 33820459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability.
    Zhou Y; Lauschke VM
    Clin Pharmacol Ther; 2021 Sep; 110(3):626-636. PubMed ID: 33998671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
    Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
    J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics.
    Schwarz UI; Gulilat M; Kim RB
    Cold Spring Harb Perspect Med; 2019 Feb; 9(2):. PubMed ID: 29844222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe "PREPARE" study.
    Tsermpini EE; Skokou M; Ferentinos P; Georgila E; Gourzis P; Assimakopoulos K; Patrinos GP;
    Psychiatriki; 2020; 31(4):341-351. PubMed ID: 33361064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of the Important Role of
    Taylor C; Crosby I; Yip V; Maguire P; Pirmohamed M; Turner RM
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33143137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.
    Trent RJ; Cheong PL; Chua EW; Kennedy MA
    Pathology; 2013 Jun; 45(4):357-70. PubMed ID: 23594690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards population-specific pharmacogenomics in the era of next-generation sequencing.
    Ji X; Ning B; Liu J; Roberts R; Lesko L; Tong W; Liu Z; Shi T
    Drug Discov Today; 2021 Aug; 26(8):1776-1783. PubMed ID: 33892143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
    Ji Y; Si Y; McMillin GA; Lyon E
    Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics, pharmacogenomics, and individualized medicine.
    Ma Q; Lu AY
    Pharmacol Rev; 2011 Jun; 63(2):437-59. PubMed ID: 21436344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and Challenges in Pharmacogenomics.
    Van Driest SL; Cascorbi I
    Clin Pharmacol Ther; 2021 Sep; 110(3):529-532. PubMed ID: 34412159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.